Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

MEI Pharma, Inc. - Common Stock (NQ:MEIP)

4.230 -0.040 (-0.94%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about MEI Pharma, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
MEI Pharma Announces First Patient Dosed in Clinical Study Evaluating ME-344 Plus Bevacizumab (AVASTIN®) in Patients with Previously Treated Metastatic Colorectal Cancer
From MEI Pharma, Inc.
Via Business Wire
MEI Pharma Announces Results of Special Meeting of Stockholders
From MEI Pharma, Inc.
Via Business Wire
MEI Pharma Reminds Shareholders to Vote Today FOR the Infinity Transaction
From MEI Pharma, Inc.
Via Business Wire
MEI Pharma Responds to Anson and Cable Car
From MEI Pharma, Inc.
Via Business Wire
Anson and Cable Car File Preliminary Consent Materials to Remove Entire Board of Directors at MEI Pharma, Inc.
From Anson Funds Management LP
Via GlobeNewswire
MEI Pharma Encourages Shareholders to Vote FOR the Infinity Transaction
From MEI Pharma, Inc.
Via Business Wire
MEI Pharma Postpones Special Meeting of Shareholders
From MEI Pharma, Inc.
Via Business Wire
MEI Pharma Provides Final Reminder to Shareholders to Vote Today FOR the Merger With Infinity Pharmaceuticals
From MEI Pharma, Inc.
Via Business Wire
Infinity Pharmaceuticals Says Second Proxy Advisory Firm Recommends Shareholders To Approve Proposed Merger
Infinity Pharmaceuticals Inc (NASDAQ: INFI) announced further design features of its Phase 2 MARIO-8 study in Squamous Cell Cancer of the  
Via Benzinga
MEI Pharma Reminds Shareholders to Vote FOR the Merger with Infinity Pharmaceuticals
From MEI Pharma, Inc.
Via Business Wire
MEI Pharma Highlights Recommendation by Leading Independent Proxy Advisory Firm ISS to Vote “FOR” Pending Transaction with Infinity Pharmaceuticals
From MEI Pharma, Inc.
Via Business Wire
MEI Pharma Mails Letter to Shareholders Reiterating Value Creating Potential of Proposed Transaction with Infinity Pharmaceuticals
From MEI Pharma, Inc.
Via Business Wire
MEI Pharma Responds to Anson and Cable Car
From MEI Pharma, Inc.
Via Business Wire
Anson Funds and Cable Car Capital Issue Statement Regarding the Inferior Proposed Transaction between MEI Pharma and Infinity Pharmaceuticals
From Anson Funds Management LP
Via GlobeNewswire
MEI Pharma and Infinity Pharmaceuticals Host Video Webcast Providing Overview and Update on Pending Merger to Advance Three Promising Clinical Oncology Candidates
From Infinity Pharmaceuticals, Inc.
Via Business Wire
MEI Pharma Announces Planned Departure of Chief Financial Officer Brian Drazba and Appointment of Justin File as Successor
From MEI Pharma, Inc.
Via Business Wire
MEI Pharma Announces Planned Departure of CEO Daniel P. Gold, Ph.D. and Appointment of David M. Urso as Successor
From MEI Pharma, Inc.
Via Business Wire
Anson Funds and Cable Car Capital Issue Statement Regarding MEI Pharma’s Rejection of Their Acquisition Proposal
From Anson Funds Management LP
Via GlobeNewswire
MEI Pharma Board of Directors Rejects Unsolicited Proposal
From MEI Pharma, Inc.
Via Business Wire
MEI Pharma Confirms Receipt of Unsolicited Acquisition Proposal
From MEI Pharma, Inc.
Via Business Wire
Clinical Triumph: MEI Pharma's Voruciclib Demonstrates Encouraging Activity in AML Patients
MEI Pharma Inc (NASDAQ: MEIP) announced an update to the Phase 1 study of voruciclib, an orally administered cyclin-dependent kinase 9 inhibitor, in patients with relapsed and refractory (R/R) acute... 
Via Benzinga
MEI Pharma Announces Update of Ongoing Phase 1 Study Evaluating Oral CDK9 Inhibitor Voruciclib Alone and in Combination with Venetoclax in Patients with Acute Myeloid Leukemia or B-Cell Malignancies
From MEI Pharma, Inc.
Via Business Wire
MEI Pharma Reports Third Quarter Fiscal Year 2023 Results and Operational Highlights
From MEI Pharma, Inc.
Via Business Wire
10 Short Squeeze Stocks To Watch: Getty Images, Guardforce AI And 2 Stocks Moving Up Over 1,000 Positions On The Leaderboard
Potential short squeeze plays gained steam in 2021, continued through 2022, and remain a focus of new traders looking for the next huge move. High short interest and high cost to borrow are among the... 
Via Benzinga
Here's Why MEI Pharma (MEIP) Stock Is Moving
MEI Pharma (NASDAQ: MEIP) shares are trading lower by roughly 2.54% to $4.68 Monday morning, though rebounding off the session low of $4.30, after the company announced and effected a 1-for-20 reverse... 
Via Benzinga
MEI Pharma Announces 1-for-20 Reverse Stock Split
From MEI Pharma, Inc.
Via Business Wire
MEI Pharma And 2 Other Penny Stocks Insiders Are Aggressively Buying
The Dow Jones closed slightly higher on first trading day of March. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Why Domino's Pizza Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
Infinity Pharmaceuticals Announce Merger Agreement With MEI Pharma, Share Plunge
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.